Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Q Wu

Showing results (1-10 of 201) with videos related to

Pageof 21
Sort By:
Journal of Managed Care & Specialty Pharmacy|November 2, 2015
Adherence and Persistence Among Chronic Myeloid Leukemia Patients During Second-Line Tyrosine Kinase Inhibitor TreatmentLei Chen, Eric Q Wu
Pharmacoeconomics|February 21, 2014
The role of health economics and outcomes research in health care reform in ChinaWannian Liang, Jipan Xie, Hongpeng Fu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patientsEric Q Wu, Parvez Mulani, Max H Farrell, et al.
Clinical Therapeutics|January 30, 2010
Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterolChristian Frois, Eric Q Wu, Saurabh Ray, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 27, 2007
Use of inhaled corticosteroids and healthcare costs in mild persistent asthmaGene Colice, Eric Q Wu, Howard Birnbaum, et al.
Journal of Medical Economics|November 27, 2012
Re.: Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United StatesJipan Xie, Melissa Diener, Rachael Sorg, et al.
Clinical Breast Cancer|June 15, 2012
Cost-effectiveness of denosumab compared with zoledronic acid in patients with breast cancer and bone metastasesJipan Xie, Melissa Diener, Rachael Sorg, et al.
Drugs - Real World Outcomes|November 20, 2016
Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β<sub>2</sub>-AgonistsVamsi Bollu, Annie Guérin, Geneviève Gauthier, et al.
Journal of Managed Care & Specialty Pharmacy|October 1, 2019
The Economic Burden of Nocturia on the U.S. Health Care System and Society: A National Health and Nutrition Examination Survey AnalysisJay Jhaveri, Marjolaine Gauthier-Loiselle, Patrick Gagnon-Sanschagrin, et al.
Psychological Medicine|August 16, 2006
Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approachEric Q Wu, Lizheng Shi, Howard Birnbaum, et al.
Pageof 21

Showing results (1-10 of 201) with videos related to

Sort By:
Pageof 21
Journal of Managed Care & Specialty Pharmacy|November 2, 2015
Adherence and Persistence Among Chronic Myeloid Leukemia Patients During Second-Line Tyrosine Kinase Inhibitor TreatmentLei Chen, Eric Q Wu
Pharmacoeconomics|February 21, 2014
The role of health economics and outcomes research in health care reform in ChinaWannian Liang, Jipan Xie, Hongpeng Fu, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|September 25, 2007
Mapping FACT-P and EORTC QLQ-C30 to patient health status measured by EQ-5D in metastatic hormone-refractory prostate cancer patientsEric Q Wu, Parvez Mulani, Max H Farrell, et al.
Clinical Therapeutics|January 30, 2010
Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterolChristian Frois, Eric Q Wu, Saurabh Ray, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|July 27, 2007
Use of inhaled corticosteroids and healthcare costs in mild persistent asthmaGene Colice, Eric Q Wu, Howard Birnbaum, et al.
Journal of Medical Economics|November 27, 2012
Re.: Cost-effectiveness of denosumab vs zoledronic acid for prevention of skeletal-related events in patients with solid tumors and bone metastases in the United StatesJipan Xie, Melissa Diener, Rachael Sorg, et al.
Clinical Breast Cancer|June 15, 2012
Cost-effectiveness of denosumab compared with zoledronic acid in patients with breast cancer and bone metastasesJipan Xie, Melissa Diener, Rachael Sorg, et al.
Drugs - Real World Outcomes|November 20, 2016
Readmission Risk in Chronic Obstructive Pulmonary Disease Patients: Comparative Study of Nebulized β<sub>2</sub>-AgonistsVamsi Bollu, Annie Guérin, Geneviève Gauthier, et al.
Journal of Managed Care & Specialty Pharmacy|October 1, 2019
The Economic Burden of Nocturia on the U.S. Health Care System and Society: A National Health and Nutrition Examination Survey AnalysisJay Jhaveri, Marjolaine Gauthier-Loiselle, Patrick Gagnon-Sanschagrin, et al.
Psychological Medicine|August 16, 2006
Annual prevalence of diagnosed schizophrenia in the USA: a claims data analysis approachEric Q Wu, Lizheng Shi, Howard Birnbaum, et al.
Pageof 21